ClinicalTrials.gg
CompletedNCT01828814Updated Apr 28, 2017

Different Strategies for Preventing Severe Acute Malnutrition in Niger

An observational study in Malnutrition, sponsored by Epicentre. Completed at 1 site in Niger. Open to participants aged 6 Months to 24 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-04-28.

Sponsored by Epicentre · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Prospective
Enrollment
7,836
Ages
6 Months to 24 Months
Sex
All
01

Study summary

Options for large-scale preventive distributions include fortified blended flours, ready-to-use foods and direct cash transfer either alone or in combination with family protective rations. Finding the most appropriate strategy is essential to prevent child malnutrition in countries like Niger with annual hunger gaps. Here, the investigators compare different preventive strategies on the incidence of acute malnutrition among children 6 to 23 months.

02

Conditions studied

  • Malnutrition

Browse trials for

Keywords

  • pediatrics
  • Ready-to-use Supplementary Food
  • corn soy blend
  • cash transfer
  • prevention of malnutrition
  • Niger
03

In context

Malnutrition

1,277 studies on the registry are indexed under Malnutrition; 230 are open to participants now.

This study's enrollment of 7,836 is above the median of 206 across 393 observational studies indexed under Malnutrition.

Browse Malnutrition studies →

Lead sponsor

Epicentre is the lead sponsor of 49 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 24 Months
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Children 6 to 24 months

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • resident in selected villages
  • height between 60 and 80 cm.

Exclusion criteria

Exclusion Criteria:

  • refusal to participate
05

Study design

Observational model
Ecologic or community
Time perspective
Prospective
Enrollment
7,836 participants (actual)
Patient registry
No

Groups and cohorts

  • RUSF (500kcal/day) and cash transfer

    Monthly distributions of Ready-to-use Supplementary Food (RUSF) 500kcal per day associated with cash transfer during hunger gap (5 months) then RUSF 500kcal/day for 10 months

  • Super Cereal Plus (SC+)

    Monthly distributions of SC+ 800kcal per day during hunger gaps (5 months twice) and SC+ 400kcal per day in-between (5 months)

  • RUSF

    Monthly distributions of Ready-to-use Supplementary Food (RUSF) 500kcal per day during hunger gaps (5 months twice) and RUSF 250kcal per day in-between (5 months)

  • RUSF (250kcal/day) and cash transfer

    Monthly distributions of Ready-to-use Supplementary Food (RUSF) 250kcal per day associated with cash transfer during hunger gap (5 months) then RUSF 250kcal/day for 10 months

  • SC+ and cash transfer

    Monthly distributions of Super Cereal Plus (SC+) 800 kcal per day associated with cash transfer during hunger gap (5 months)

  • SC+ and household ration

    Monthly distributions of Super Cereal Plus (SC+) 800 kcal per day associated with food ration for household support during hunger gap (5 months)

  • Cash transfer

    Monthly distributions of cash transfer only during hunger gap (5 months)

06

What researchers measure

Primary outcomes

  1. Incidence of severe acute malnutrition

    Severe acute malnutrition was defined as : Weight for Height Z-score (WHO Standards 2006)\< -3 and/or mid-upper arm circumference (MUAC) \< 115mm and/or bipedal oedema. MUAC was measured at the midpoint of a child's left arm with a plastic measuring tape with a precision of 1 mm. These indicators were evaluated monthly during the entire follow-up (15 months).

    Time frame: 15 months

Secondary outcomes

  1. Mortality

    Mortality events include all reports for which the cause for absence from surveillance visits was reported to be death by a family member.

    Time frame: duration of follow-up (15 months)

07

Study locations

1 site
  • Villages
    Madarounfa, Maradi, Niger
08

References and documents

Publications

  • Sayyad-Neerkorn J, Langendorf C, Roederer T, Doyon S, Mamaty AA, Woi-Messe L, Manzo ML, Harouna S, de Pee S, Grais RF. Preventive Effects of Long-Term Supplementation with 2 Nutritious Food Supplements in Young Children in Niger. J Nutr. 2015 Nov;145(11):2596-603. doi: 10.3945/jn.115.213157. Epub 2015 Sep 30. PubMed 26423742 ↗
  • Langendorf C, Roederer T, de Pee S, Brown D, Doyon S, Mamaty AA, Toure LW, Manzo ML, Grais RF. Preventing acute malnutrition among young children in crises: a prospective intervention study in Niger. PLoS Med. 2014 Sep 2;11(9):e1001714. doi: 10.1371/journal.pmed.1001714. eCollection 2014 Sep. PubMed 25180584 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2011, a primary completion of Oct 2012 and a completion of Oct 2012. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 4, 2013
First posted
Apr 11, 2013
Start
Jul 2011
Primary completionActual
Oct 2012
CompletionActual
Oct 2012
Last update
Apr 28, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 28, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01828814
Lead sponsor
Epicentre
Collaborators
United Nations World Food Programme (WFP)
Responsible party
Sponsor
First posted
Apr 11, 2013
Start date
Jul 2011
Primary completion
Oct 2012
Completion
Oct 2012
Last update
Apr 28, 2017

Study contacts

Céline Langendorf, MPH
principal investigator · Epicentre

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion